Ophthalmic Drugs Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Ophthalmic</strong> <strong>Drugs</strong> <strong>Market</strong> Report Overview<br />
• <strong>Ophthalmic</strong> drugs are the drugs that are used for the treatment of eye diseases and<br />
disorders.<br />
• The ophthalmic drugs market is growing due to increase in prevalence of eye disorders<br />
and the use of combination therapies.<br />
• Combination therapies have various advantages over traditional medication such as<br />
improved patient compliance and efficacy.<br />
• The drivers that support the growth of ophthalmic drug market are aging population,<br />
changing lifestyle, technological changes, and increase in healthcare spending.<br />
• Lack of awareness among people regarding eye diseases and disorders, absence of<br />
health insurance in developing countries are some of the challenges faced by the<br />
ophthalmic drugs market.<br />
• <strong>Ophthalmic</strong> drug <strong>Market</strong> analysis by Treatment:<br />
The market is segmented into Dry eye drugs, Retinal drugs, Antiinflammatory/allergy/infective<br />
drugs, Anti-glaucoma drugs. Glaucoma has the largest<br />
market share in the ophthalmic drugs market.
Change language